Abstract:OBJECTIVE:To investigate the preventive effect of bacillus Calmette-Guerin (BCG) vaccination in early life on airway inflammation and mucus production in a murine model of asthma. METHODS:Twenty-five newborn C57BL/6 mice were divided into three groups including group A (saline sensitized/challenged mice, n = 8), group B [ovalbumin (OVA) sensitized/challenged mice, n = 9], group C (OVA sensitized/challenged mice treated by BCG in early life, n = 8). Mice in group C were subcutaneously injected by 25 microl BCG (10(3) CFU) four times at 0 week, 1st week, 2nd week and 3rd week of age respectively, while mice in group A and B were injected by the same volume of saline solution. Mice were sensitized on day 42 and 56 by saline (group A) or OVA (group B and C) and challenged from day 66 to 68 by saline (group A) or OVA (group B and C) repeatedly. Samples were collected at 48 h after the last OVA challenge. The outcome measurements included eosinophil count in bronchoalveolar lavage fluid (BALF), periodic acid-schiff reaction (PAS) staining of lung tissues, the goblet cell hyperplasia ratio (HR) and the epithelial cell mucus occupying ratio (MOR). The mRNA expression of mucus gene (MUC5AC) was measured by reverse trancription-polymerase chain reaction (RT-PCR). RESULTS:The total cells in BALF in group B (123.8 +/- 14.5) x 10(4)/ml] and that in group C [(77.4 +/- 14.1) x 10(4)/ml] were increased significantly as compared with that in group A [(15.0 +/- 1.4) x 10(4)/ml, P < 0.01, P < 0.01], but there was no significant difference between group B and group C (P > 0.05). The number of eosinophils in BALF in group B [(78.220 +/- 11.770) x 10(4)/ml] and that in group C [(24.430 +/- 7.020) x 10(4)/ml] were increased significantly when compared with that in group A [(0.090 +/- 0.020) x 10(4)/ml, P < 0.01, P < 0.05], and that in group C was significantly reduced when compared with that in group B (P < 0.01). The HR and MOR in group B [(41.80 +/- 4.09)/mm, (28.43 +/- 2.75)% respectively] and those in group C [(21.58 +/- 5.09)/mm, (9.43 +/- 2.30)% respectively] were increased significantly when compared with those in group A [(3.00 +/- 1.20)/mm, (0.75 +/- 0.29)% respectively, P < 0.01, P < 0.01], but those in group C were significantly reduced when compared with those in group B (P < 0.01). The mRNA expression of MUC5AC in group B (1.07 +/- 0.03) and that in group C (0.86 +/- 0.05) were increased significantly when compared with that in group A (0.64 +/- 0.08, P < 0.01, P < 0.01), but that in group C were significantly reduced when compared with that in group B (P < 0.01). CONCLUSION:BCG vaccination in early life can inhibit the development of airway inflammation and mucus production in a murine model of asthma.

[Effects of Vaccae on Airway Inflammation and Th1/Th2 Cytokines in Sensitized Mice].

[Effects of Vaccae on Airway Contraction and Inflammation in Asthmatic Guinea Pigs].

Carbocistein improves airway remodeling in asthmatic mice

Mycobacterium vaccae alleviates allergic airway inflammation and airway hyper‐responsiveness in asthmatic mice by altering intestinal microbiota

Mycobacterium vaccae attenuates airway inflammation by inhibiting autophagy and activating PI3K/Akt signaling pathway in OVA-induced allergic airway inflammation mouse model

Expression of IFN-γ,IL-4 and IL-17A in asthmatic mice vaccinated with BCG and HepB in neonatal period

Effects of Bacillus Calmette-Guerin on airway inflammation, T helper cell differentiation and serum OVA-specific IgE levels in a mouse model of asthma

Effects of Ozone Repeated Short Exposures on the Airway/lung Inflammation, Airway Hyperresponsiveness and Mucus Production in a Mouse Model of Ovalbumin-Induced Asthma.

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Effects of Mycobacteria Vaccine on Asthma Model in Mice

Low Doses Of Exogenous Interferon-Gamma Attenuated Airway Inflammation Through Enhancing Fas/Fasl-Induced Cd4(+) T Cell Apoptosis In A Mouse Asthma Model

Lactobacillus fermentum CECT5716 Alleviates the Inflammatory Response in Asthma by Regulating TLR2/TLR4 Expression

Effects of bacillus Calmette -Guerin vaccinated at ovalbumin sensitization on airway inflammation in a mouse model of asthma

Effects of respiratory syncytial virus(RSV) infection on the airway hyperresponesivenesss of ovabumin(OVA)-sensitized Balb/C mice

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Effect of anti-CD8mAb on airway inflammation of Balb/c mice with respiratory syncytial virus-induced asthma

Effects of the immunomodulatory agent Cordyceps militaris on airway inflammation in a mouse asthma model

[The Preventive Effect of Bacillus Calmette-Guerin Vaccination in Early Life on Airway Inflammation and Mucus Production in a Murine Model of Asthma].

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

Effect of Lactobacillus rhamnosus GG immunopathologic changes in chronic mouse asthma model

Effect of Interferon-Gamma on Airway Inflammation and T Lymphoid Cells in Lung and Serum IgE Level in Murin Asthmatic Models